Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone and Ethinyl Estradiol for Adult Height in Turner Syndrome
NCT00001221Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Sep 1987
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of somatropin and ethinyl estradiol in Turner syndrome (TS) (4 arms), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoint: Adult Height. Started Sep 1987; status: completed.
02
Drugs
somatropinethinyl estradiol
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NCT00001221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001221.